GoodRx Holdings GDRX 深 滬
已收盤 09-20 16:00:00 美东时间
6.91
-0.170
-2.40%
華盛通- 最 高7.11
- 今 開7.03
- 成交量 149.12万股
- 最 低 6.88
- 昨 收 7.08
- 總市值 27.29亿
- 52周最高 9.2599
- 市盈率 靜 --
- 換手率 0.38%
- 52周最低 4.135
- 委 比 -83.01%
- 總股本 3.95亿
- 歷史最高 64.219
- 量 比 1.58
- 振 幅 3.25%
- 歷史最低 3.82
- 每 手 1
- 風險率 1.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Subdued Growth No Barrier To GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Price
When you see that almost half of the companies in the Healthcare Services indus...
09-12 18:47
GoodRx Holdings Chief Accounting Officer Romin Nabiey Sells 55% Of Holding
We wouldn't blame GoodRx Holdings, Inc. (NASDAQ:GDRX) shareholders if they were...
08-16 19:13
UBS Maintains Neutral on GoodRx Holdings, Lowers Price Target to $8.5
UBS analyst Eric Sheridan maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the price target from $9 to $8.5.
08-09 23:04
快讯 | GoodRx Holdings Inc: 瑞银将目标价从9美元下调至8.5美元
GoodRx Holdings Inc : UBS Cuts Target Price to $8.5 From $9
08-09 22:13
GoodRx Holdings: Hold Rating Amidst Operational Strengths and Market Uncertainties
Morgan Stanley analyst Craig Hettenbach has maintained their neutral stance on ...
08-09 19:20
GoodRx tumbles 21% following guidance adjustments, quarterly EPS miss
GoodRx (NASDAQ:GDRX) is down ~21% in Thursday trading after announcing a Q3 revenue guidance range that did not include the consensus and saying that prior full-year guidance will be in the low-end of...
08-09 00:39
GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges
GoodRx reported Q2 revenue of $200.61M, a 6% YoY increase. Prescription transactions revenue rose 7%, driven by 8% growth in Monthly Active Consumers. The company expects FY 2024 revenue at the lower end of $800 million-$810 million, below consensus.
08-09 00:04
快讯 | GoodRx Holdings Inc FY2024营收预估为8.064亿美元--LSEG IBES 数据
GoodRx Holdings Inc FY2024 Rev View $806.4 Mln -- LSEG IBES Data
08-08 18:13
GoodRx FY24 Revenue Outlook Lower End Of Previous Range Of $800M-$810M Vs, $806.38M
Guidance For the third quarter and full year 2024, management is anticipating the following: $ in millions 3Q 2024 3Q 2023 YoY
08-08 18:10
